CurrentEndo
Get Weekly

Topic · page 33 of 35

Osteoporosis, bone & mineral

Osteoporosis in women and men, fracture risk and bone density, fragility fractures and their secondary prevention, bone drugs and treatment sequence; hyperparathyroidism and hypoparathyroidism, vitamin D, calcium and phosphate disorders, rare metabolic bone disease

Briefs 1,281–1,320 of 1,367 placed here, newest publication first

Briefs in Osteoporosis, bone & mineral

Newest publication first

  1. Osteoporos Int

    A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis

    Guideline or statement

  2. Osteoporos Int

    DXA-based bone strain index in normocalcemic primary hyperparathyroidism

    Case-control study

  3. Eur J Endocrinol

    High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture

    Research article

  4. Osteoporos Int

    The clinical utility of the BMD-related comprehensive genome-wide polygenic score in identifying individuals with a high risk of osteoporotic fractures

    Cohort study

  5. Clin Endocrinol (Oxf)

    Comparison of 4D computed tomography and F‐18 fluorocholine PET for localisation of parathyroid lesions in primary hyperparathyroidism: A systematic review and meta‐analysis

    Meta-analysis

  6. Endocr Pract

    Intact Fibroblast Growth Factor 23 Concentrations in Hypophosphatemic Disorders

    Diagnostic or prognostic study

  7. Osteoporos Int

    A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK

    Cohort study

  8. J Clin Endocrinol Metab

    Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population

    Research article

  9. Osteoporos Int

    Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study

    Cohort study

  10. Osteoporos Int

    Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study

    Cohort study

  11. Osteoporos Int

    The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review

    Research article

  12. Osteoporos Int

    Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice

    Meta-analysis

  13. J Clin Endocrinol Metab

    Genotypic and Phenotypic Spectrum and Pathogenesis of WNT1 Variants in a Large Cohort of Patients With OI/Osteoporosis

    Cohort study

  14. JAMA Netw Open

    Artificial Neural Network Modeling to Predict Neonatal Metabolic Bone Disease in the Prenatal and Postnatal Periods

    Diagnostic or prognostic study

  15. Ann Intern Med

    Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians

    Meta-analysis

  16. Ann Intern Med

    Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians

    Guideline or statement

  17. J Bone Miner Res

    Effect of Abaloparatide on Bone Microarchitecture Assessed by Trabecular Bone Score in Women With Osteoporosis: Post Hoc Analysis of ACTIVE and ACTIVExtend

    Secondary analysis

  18. Clin Endocrinol (Oxf)

    Coronary artery disease and its vascular associates in patients with chronic nonsurgical hypoparathyroidism

    Cross-sectional study

  19. Osteoporos Int

    Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis

    Cohort study

  20. Osteoporos Int

    Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)

    Cross-sectional study

  21. Clin Endocrinol (Oxf)

    Novel SLC12A3 gene mutations and clinical characteristics in two pedigrees with Gitelman syndrome

    Cohort study

  22. Osteoporos Int

    C-reactive protein predicts endocortical expansion but not fracture in older men: the prospective STRAMBO study

    Cohort study

  23. Osteoporos Int

    Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year

    Cohort study

  24. Osteoporos Int

    Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

    Secondary analysis

  25. J Clin Endocrinol Metab

    A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on the Treatment of Hypercalcemia of Malignancy in Adults

    Meta-analysis

  26. J Clin Endocrinol Metab

    Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline

    Guideline or statement

  27. Osteoporos Int

    Efficacy of cast immobilization versus surgical treatment for distal radius fractures in adults: a systematic review and meta-analysis

    Meta-analysis

  28. J Bone Miner Res

    Impact of Stroke History on the Risk of Recurrent Hip Fracture or Major Osteoporotic Fractures among Patients with Incident Hip Fracture: A Nationwide Cohort Study

    Cohort study

  29. Osteoporos Int

    A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis

    Meta-analysis

  30. J Clin Endocrinol Metab

    Effect of Conventional Treatment on Dental Complications and Ectopic Ossifications Among 30 Adults With XLH

    Cohort study

  31. Osteoporos Int

    Primary hyperparathyroidism and fracture probability

    Cohort study

  32. J Clin Endocrinol Metab

    Effects of 25-Hydroxyvitamin D Levels on Renal Function: A Bidirectional Mendelian Randomization Study

    Research article

  33. Lancet Diabetes Endocrinol

    Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study

    Cross-sectional study

  34. J Clin Endocrinol Metab

    A Computed Tomography-based Radiomics Nomogram for Predicting Osteoporotic Vertebral Fractures: A Longitudinal Study

    Case-control study

  35. Obesity (Silver Spring)

    Metabolically favorable adiposity and bone mineral density: a Mendelian randomization analysis

    Research article

  36. J Clin Endocrinol Metab

    Consensus and Controversial Aspects of Vitamin D and COVID-19

    Guideline or statement

  37. J Clin Endocrinol Metab

    Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women—A J-shaped Relationship

    Cohort study

  38. J Bone Miner Res

    Increased Advanced Glycation Endproducts, Stiffness, and Hardness in Iliac Crest Bone From Postmenopausal Women With Type 2 Diabetes Mellitus on Insulin

    Cross-sectional study

  39. Osteoporos Int

    Frailty and risk of subsequent fracture among older adults presenting to hospital with a minimal trauma fracture

    Cohort study

  40. Osteoporos Int

    Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019

    Cohort study

All 1,367 Briefs in ExploreShowing Briefs 1,281–1,320 of 1,367, newest first